Stay updated with breaking news from Jay Bradner. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Investegate announcements from NOVARTIS AG CHF0.50(REGD), Novartis announces T-Charge™, next-generation CAR-T platform with first-in-human data at ASH 2021
Unlike some of its Big Pharma peers, Novartis has not been at the forefront of creating new vaccines and treatments against COVID. Now, however, it’s taking its massive R&D budget and targeting not just the current pandemic, but all coronaviruses.
This 30-year collaboration is unique in its longevity and open scientific exchange. Aiming to accelerate the translation of scientific discoveries into improved cancer therapies, Dana-Farber Cancer Institute and Novartis have renewed a longstanding research collaboration and – for the first time – are inviting grant applications from a broad range of Boston academic medical institutions. Under this renewal, more than $11 million will be available annually for research funding through the Dana-Farber/Novartis Drug Discovery and Translational Research Program (DDTRP). The collaboration, wh...
Caption: The Future Founders Initiative aims to increase the fraction of MIT female faculty who found companies from less than 10 percent to 25 percent by 2024. Caption: Future Founders collaborators (clockwise from top left) Susan Hockfield, MIT president emerita; Harvey Lodish, professor of biology and biomedical engineering; and Sangeeta Bhatia, the John and Dorothy Wilson Professor of Health Sciences and Technology and Electrical Engineering and Computer Science. Previous image Next image The gender disparity in biotech r...
These updates are republished press releases and communications from members of the Science|Business Network Novartis and the Bill & Melinda Gates Foundation collaborate to develop gene therapy for sickle cell disease Project brings together Novartis drug discovery and gene therapy expertise and funding support from the Gates Foundation Agreement aims to address disparity in access to treatments and to prioritize populations and regions that bear the greatest burden of sickle cell disease in the search for curative therapies Effort expands on Novartis commitment to sickle cell disease, w...